title: [Increased risk of cancer using insulin and insulin analogues?].
authors.affiliation: KIinik und PoIikIinik für Innere Medizin I, Universität Regensburg. andreas.schaeffler@klinik.uni-regensburg.de
authors.forename: A
authors.initials: A
authors.lastname: Schäffler
mesh_terms: D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D005858:Germany; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007328:Insulin / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000069036:Insulin Glargine; D007333:Insulin Resistance / Q000502:physiology; D049528:Insulin, Long-Acting; D009369:Neoplasms / Q000139:chemically induced*; D009765:Obesity / Q000503:physiopathology; D017526:Receptor, IGF Type 1 / Q000187:drug effects; D011972:Receptor, Insulin / Q000187:drug effects; D012306:Risk
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine; D017526:Receptor, IGF Type 1; D011972:Receptor, Insulin